Combined liver-kidney transplantation in children: indications and outcome

Scott M Sutherland1, Steven R Alexander, Minnie M Sarwal

  • 1Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. suthersm@stanford.edu

Pediatric Transplantation
|November 13, 2008
PubMed

Insights

Combined liver and kidney transplantation (CLKT) offers a viable option for children with severe liver and kidney disease, particularly those with rare primary conditions or unexplained hepatic and renal failure.

Area of Science:

  • Pediatric Medicine
  • Nephrology
  • Hepatology
  • Transplantation Surgery

Background:

  • Combined liver and kidney transplantation (CLKT) is an infrequent but viable procedure for pediatric patients.
  • Indications include rare primary diseases affecting both organs and cases of concomitant hepatic and renal failure.

Purpose of the Study:

  • To review the indications for CLKT in children.
  • To analyze the outcomes following CLKT in pediatric populations.
  • To address specific primary diseases and general hepatic/renal failure scenarios.

Main Methods:

  • Review of existing literature and clinical data on pediatric CLKT.
  • Analysis of patient cohorts undergoing CLKT for various indications.
  • Evaluation of disease-specific and general failure indications.

Main Results:

  • CLKT is a critical intervention for select pediatric cases.
  • Outcomes are influenced by the underlying etiology of liver and kidney disease.
  • The procedure addresses both primary organ diseases and secondary failure syndromes.

Conclusions:

  • CLKT is an established option for children with severe, combined liver and kidney dysfunction.
  • Understanding specific disease indications and general failure patterns is crucial for patient selection.
  • Further research can optimize outcomes for pediatric CLKT recipients.